Hendrik Ungefroren

7.8k total citations
130 papers, 5.4k citations indexed

About

Hendrik Ungefroren is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hendrik Ungefroren has authored 130 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 70 papers in Oncology and 22 papers in Cancer Research. Recurrent topics in Hendrik Ungefroren's work include Pancreatic and Hepatic Oncology Research (43 papers), TGF-β signaling in diseases (41 papers) and Cancer Cells and Metastasis (21 papers). Hendrik Ungefroren is often cited by papers focused on Pancreatic and Hepatic Oncology Research (43 papers), TGF-β signaling in diseases (41 papers) and Cancer Cells and Metastasis (21 papers). Hendrik Ungefroren collaborates with scholars based in Germany, Austria and United States. Hendrik Ungefroren's co-authors include Hendrik Lehnert, Holger Kalthoff, Ralf Hass, Fred Fändrich, Frank Gieseler, Susanne Sebens, Juliane von der Ohe, Bence Sipos, Roland Kaufmann and H. Schäfer and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.

In The Last Decade

Hendrik Ungefroren

128 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hendrik Ungefroren Germany 41 2.9k 2.3k 1.2k 1.0k 687 130 5.4k
Pipsa Saharinen Finland 36 3.5k 1.2× 2.6k 1.1× 1.1k 0.9× 930 0.9× 548 0.8× 69 6.5k
Gopesh Srivastava Hong Kong 47 3.2k 1.1× 1.9k 0.8× 960 0.8× 923 0.9× 626 0.9× 151 5.8k
Robert G. Ramsay Australia 50 3.6k 1.2× 2.1k 0.9× 934 0.8× 939 0.9× 1.0k 1.5× 176 6.5k
Kazuhito Naka Japan 40 4.0k 1.4× 2.0k 0.9× 1.0k 0.9× 1.6k 1.5× 500 0.7× 92 7.3k
Jacob Pe’er Israel 39 3.6k 1.2× 1.8k 0.8× 806 0.7× 1.2k 1.2× 486 0.7× 149 7.7k
Karin Vanderkerken Belgium 51 4.5k 1.5× 3.2k 1.4× 1.2k 1.1× 1.4k 1.4× 298 0.4× 227 7.9k
Gloria H. Su United States 43 2.8k 0.9× 2.4k 1.0× 905 0.8× 1.3k 1.3× 823 1.2× 91 5.8k
Karen E. Pollok United States 38 2.7k 0.9× 1.7k 0.7× 1.6k 1.4× 671 0.7× 353 0.5× 142 5.6k
Qiang Wang China 40 3.0k 1.0× 1.4k 0.6× 864 0.7× 814 0.8× 532 0.8× 191 5.3k
Hidayatullah G. Munshi United States 45 2.3k 0.8× 2.5k 1.1× 803 0.7× 1.1k 1.1× 518 0.8× 106 4.8k

Countries citing papers authored by Hendrik Ungefroren

Since Specialization
Citations

This map shows the geographic impact of Hendrik Ungefroren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hendrik Ungefroren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hendrik Ungefroren more than expected).

Fields of papers citing papers by Hendrik Ungefroren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hendrik Ungefroren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hendrik Ungefroren. The network helps show where Hendrik Ungefroren may publish in the future.

Co-authorship network of co-authors of Hendrik Ungefroren

This figure shows the co-authorship network connecting the top 25 collaborators of Hendrik Ungefroren. A scholar is included among the top collaborators of Hendrik Ungefroren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hendrik Ungefroren. Hendrik Ungefroren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ungefroren, Hendrik. (2025). PDCD10/CCM3, a potential target for pancreatic ductal adenocarcinoma?. Clinical Science. 139(3). 281–286. 1 indexed citations
2.
Ungefroren, Hendrik, Björn Konukiewitz, Rüdiger Braun, et al.. (2024). RAC1b Collaborates with TAp73α-SMAD4 Signaling to Induce Biglycan Expression and Inhibit Basal and TGF-β-Driven Cell Motility in Human Pancreatic Cancer. Biomedicines. 12(1). 199–199. 3 indexed citations
3.
Braun, Rüdiger, Maren Drenckhan, Axel Künstner, et al.. (2023). Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response. Cells. 12(4). 587–587. 1 indexed citations
4.
Ungefroren, Hendrik, Björn Konukiewitz, Rüdiger Braun, et al.. (2023). TAp73 Inhibits EMT and Cell Migration in Pancreatic Cancer Cells through Promoting SMAD4 Expression and SMAD4-Dependent Inhibition of ERK Activation. Cancers. 15(15). 3791–3791. 5 indexed citations
5.
Ungefroren, Hendrik, Axel Künstner, Hauke Busch, et al.. (2022). Differential Effects of Somatostatin, Octreotide, and Lanreotide on Neuroendocrine Differentiation and Proliferation in Established and Primary NET Cell Lines: Possible Crosstalk with TGF-β Signaling. International Journal of Molecular Sciences. 23(24). 15868–15868. 7 indexed citations
6.
Ungefroren, Hendrik, Leonardo Vinícius Monteiro de Assis, Rüdiger Braun, et al.. (2022). The Quasimesenchymal Pancreatic Ductal Epithelial Cell Line PANC-1—A Useful Model to Study Clonal Heterogeneity and EMT Subtype Shifting. Cancers. 14(9). 2057–2057. 18 indexed citations
7.
8.
9.
Luley, Kim Barbara, Axel Künstner, Hauke Busch, et al.. (2020). A Comprehensive Molecular Characterization of the Pancreatic Neuroendocrine Tumor Cell Lines BON-1 and QGP-1. Cancers. 12(3). 691–691. 34 indexed citations
10.
Ungefroren, Hendrik, et al.. (2020). The Small GTPase RAC1B: A Potent Negative Regulator of-and Useful Tool to Study-TGFβ Signaling. Cancers. 12(11). 3475–3475. 13 indexed citations
11.
Ungefroren, Hendrik, Christian Fiedler, Koichiro Mihara, et al.. (2019). RAC1B Suppresses TGF-β1-Dependent Cell Migration in Pancreatic Carcinoma Cells through Inhibition of the TGF-β Type I Receptor ALK5. Cancers. 11(5). 691–691. 20 indexed citations
12.
Açil, Yahya, Björn Möller, Jörg Wiltfang, Fred Fändrich, & Hendrik Ungefroren. (2017). Programmable cells of monocytic origin as a source of osteochondroprogenitors: Effect of growth factors on osteogenic differentiation. Journal of Cranio-Maxillofacial Surgery. 45(9). 1515–1520. 2 indexed citations
13.
Bartscht, Tobias, Dirk Rades, Roland Kaufmann, et al.. (2016). TGF-β Signal Transduction in Pancreatic Carcinoma Cells is Sensitive to Inhibition by the Src Tyrosine Kinase Inhibitor AZM475271. Anti-Cancer Agents in Medicinal Chemistry. 17(7). 966–972. 3 indexed citations
14.
Ungefroren, Hendrik, Frank Gieseler, Stephanie Fliedner, & Hendrik Lehnert. (2015). Obesity and cancer. Hormone Molecular Biology and Clinical Investigation. 21(1). 5–15. 35 indexed citations
15.
16.
Ungefroren, Hendrik, Stephanie Groth, Ayman Hyder, et al.. (2010). The Generation of Programmable Cells of Monocytic Origin Involves Partial Repression of Monocyte/Macrophage Markers and Reactivation of Pluripotency Genes. Stem Cells and Development. 19(11). 1769–1780. 16 indexed citations
17.
Held‐Feindt, Janka, Kirsten Hattermann, Susanne Sebens Müerköster, et al.. (2010). CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs). Experimental Cell Research. 316(9). 1553–1566. 124 indexed citations
18.
Geismann, Claudia, Dorothee Koch, Frank Bergmann, et al.. (2009). Up-regulation of L1CAM in Pancreatic Duct Cells Is Transforming Growth Factor β1– and Slug-Dependent: Role in Malignant Transformation of Pancreatic Cancer. Cancer Research. 69(10). 4517–4526. 85 indexed citations
19.
Warnecke, G., M. Avşar, Jens Gottlieb, et al.. (2009). Correlation of Donor Leukocyte Chimerism With Pulmonary Allograft Survival After Immunosuppressive Drug Withdrawal in a Porcine Model. Transplantation. 87(10). 1468–1477. 6 indexed citations
20.
Ungefroren, Hendrik, M Voss, Christian Roeder, et al.. (1998). Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.. PubMed. 58(8). 1741–9. 189 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pipsa Saharinen Breakdown of academic impact, for papers by Gopesh Srivastava Breakdown of academic impact, for papers by Robert G. Ramsay Breakdown of academic impact, for papers by Kazuhito Naka Breakdown of academic impact, for papers by Jacob Pe’er Breakdown of academic impact, for papers by Karin Vanderkerken Breakdown of academic impact, for papers by Gloria H. Su Breakdown of academic impact, for papers by Karen E. Pollok Breakdown of academic impact, for papers by Qiang Wang Breakdown of academic impact, for papers by Hidayatullah G. Munshi
Rankless by CCL
2026